Skip to main content
OpenTrials
Completed

NCT Number: NCT04761211

Effect and Safety of Smart Bra (PUMCH)

This is a multicenter, prospective clinical study was conducted to evaluate the safety and effectiveness of Xiehe smart bra for breast disease screening in outpatients with breast surgery. According to the patients' wishes and written informed consent, they were randomly assigned to the study group. A total of 2000 patients were expected to be enrolled. The training group: validation group = 1:1.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Breast Surgery Department of PUMCH

Beijing, Beijing Municipality, 100032, China

About this study

This study is a randomized, open, multicenter clinical study. It will be conducted in Peking Union Medical College Hospital, Shanxi Provincial People's Hospital, Beijing Third Hospital, Zhalantun ZhongMeng hospital, Chongqing Medical University affiliated university town hospital, Shenzhen People's Hospital and other national hospitals. A total of 2000 subjects are expected to participate. The patients in the group wore the device for about 3 minutes, and took photos of 5 breast sites. After that, the artificial intelligence learning was carried out on the photos of the training group. For the photos of the verification group, the algorithm obtained by the training group was compared with the existing artificial intelligence algorithms of ultrasound and molybdenum target. During the follow-up, the safety of the product was evaluated. According to the basic principles of safety and performance of who international general GHTF (sg1-n020r5) medical devices.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are going to receive breast ultrasound and molybdenum target in breast surgery clinic;
  • Female patients (18-80 years old);
  • Signed written informed consent approved by the relevant institutional review board (IRB) or independent ethics committee (IEC)

Exclusion criteria

  • The subjects were pregnant or lactating;
  • Patients with nipple discharge;
  • Known allergy to bra materials;
  • The patients who had received breast surgery or breast puncture within half a year;
  • Patients with skin diseases.

Treatment and study plan

smart bra

Device

This is a patented infrared breast examination bra

Primary outcomes

  1. Sensitivity

    Time frame: baseline

    Using ultrasound and / or pathological results as the gold standard, the positive rates of breast diseases (benign breast diseases and malignant breast diseases) detected by smart bra are recorded.

Secondary outcomes

  1. Specificity

    Time frame: baseline

    Using ultrasound and / or pathological results as the gold standard, the probability of no breast disease (benign breast disease, malignant breast disease) are recorded

Other outcomes

  1. Number of adverse events assessed by CTCAE v4.0

    Time frame: baseline; 3months

    Number of participants with smart-bra related adverse events as assessed by CTCAE v4.0

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Registry information

Official study title

Effect and Safety of Smart Bra of Peking Union Medical College & Hospital

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Feb 18, 2021
Registry last updated
Oct 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.